tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Shandong Boan Biotech Expects Profit Surge

Shandong Boan Biotech Expects Profit Surge

Shandong Boan Biotechnology Company., Limited. Class H (HK:6955) has released an update.

Elevate Your Investing Strategy:

Shandong Boan Biotechnology Co., Ltd. has issued a positive profit alert, expecting to report a profit of over RMB 60 million for the first half of 2024, a significant turnaround from the RMB 119 million loss in the same period the previous year. This anticipated profit is credited to increased sales of their products, especially the first domestically produced denosumab injection, cost reductions from manufacturing process improvements, and efficient management. The company advises shareholders and potential investors to await the official interim results announcement due in August 2024.

For further insights into HK:6955 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1